According to a filing submitted to the U.S. Securities and Exchange Commission, DarioHealth has extended its President and Chief Business Officer's medical leave indefinitely.

This personnel change indicates a continued vacancy in the company’s executive team due to health reasons. The company has not yet disclosed further details regarding a specific timetable for the executive’s return or any interim replacement arrangements. The long-term absence from such a key management position may raise concerns among investors about the continuity of the company’s operations and execution of its business strategy. The market will closely monitor whether DarioHealth will subsequently announce a transitional management plan to ensure smooth business operations.